423 related articles for article (PubMed ID: 20101004)
21. beta-Amyloid efflux mediated by p-glycoprotein.
Lam FC; Liu R; Lu P; Shapiro AB; Renoir JM; Sharom FJ; Reiner PB
J Neurochem; 2001 Feb; 76(4):1121-8. PubMed ID: 11181832
[TBL] [Abstract][Full Text] [Related]
22. Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer's disease mouse model.
Mohamed LA; Keller JN; Kaddoumi A
Biochim Biophys Acta; 2016 Apr; 1862(4):778-787. PubMed ID: 26780497
[TBL] [Abstract][Full Text] [Related]
23. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.
Cirrito JR; Deane R; Fagan AM; Spinner ML; Parsadanian M; Finn MB; Jiang H; Prior JL; Sagare A; Bales KR; Paul SM; Zlokovic BV; Piwnica-Worms D; Holtzman DM
J Clin Invest; 2005 Nov; 115(11):3285-90. PubMed ID: 16239972
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
25. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
26. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
[TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
Chai AB; Leung GKF; Callaghan R; Gelissen IC
FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987
[TBL] [Abstract][Full Text] [Related]
28. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cholesterol efflux by amyloid beta secretion.
Umeda T; Mori H; Zheng H; Tomiyama T
J Neurosci Res; 2010 Jul; 88(9):1985-94. PubMed ID: 20155813
[TBL] [Abstract][Full Text] [Related]
30. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice.
Kitaguchi H; Tomimoto H; Ihara M; Shibata M; Uemura K; Kalaria RN; Kihara T; Asada-Utsugi M; Kinoshita A; Takahashi R
Brain Res; 2009 Oct; 1294():202-10. PubMed ID: 19646974
[TBL] [Abstract][Full Text] [Related]
31. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
Wang C; Sun B; Zhou Y; Grubb A; Gan L
J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
[TBL] [Abstract][Full Text] [Related]
33. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.
Deo AK; Borson S; Link JM; Domino K; Eary JF; Ke B; Richards TL; Mankoff DA; Minoshima S; O'Sullivan F; Eyal S; Hsiao P; Maravilla K; Unadkat JD
J Nucl Med; 2014 Jul; 55(7):1106-11. PubMed ID: 24842892
[TBL] [Abstract][Full Text] [Related]
34. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
35. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
36. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
[TBL] [Abstract][Full Text] [Related]
37. MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-β peptides: implications for the pathogenesis and therapy of Alzheimer's disease.
Jedlitschky G; Vogelgesang S; Kroemer HK
Clin Pharmacol Ther; 2010 Oct; 88(4):441-3. PubMed ID: 20856238
[TBL] [Abstract][Full Text] [Related]
38. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
Deane R; Singh I; Sagare AP; Bell RD; Ross NT; LaRue B; Love R; Perry S; Paquette N; Deane RJ; Thiyagarajan M; Zarcone T; Fritz G; Friedman AE; Miller BL; Zlokovic BV
J Clin Invest; 2012 Apr; 122(4):1377-92. PubMed ID: 22406537
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
